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∗ Tel.: +81 798456553; fax: +81 798456551.his issue of JC Cases marks a special event in the life of the
ournal because I have taken over as Editor-in-Chief from
r Hiroshi Ito at Okayama University. JC Cases is a peer-reviewed
nline journal dedicated to predominantly publishing case report
rticles in the cardiovascular ﬁeld. JC Cases was born in February
010 as a daughter of the ofﬁcial journal of the Japan College
f Cardiology (Journal of Cardiology, JC)  when Dr Chuwa Tei served
s the third Editor-in-Chief of JC.  JC Cases was expanded during
he past 2–3 years when Dr Ito served as the second
ditor-in-Chief of JC Cases. The number of submitted manuscripts
as increased and more than doubled in 2013 compared with
010. Manuscripts are now sent not only from Japan, but also
rom most countries around the world. The journal was  initially
ublished on a bi-monthly basis, but is now published on a
onthly basis since 2012. Thus, there is no doubt that this journal
as been strongly supported by many cardiologists, cardiac
urgeons, and other people working in the cardiovascular ﬁeld.
ne might wonder whether there are still rare cardiovascular
iseases or pathological states that are worth publishing. It is
ertainly an important mission of this journal to publish such
eports of rare cases, but I believe it is just a small part of our
ission. Currently we have to pay attention to results of mega
rials or the evidence in the decision-making particularly of
herapeutic strategies in individual patients. However, there is no
ule without exception, and there are considerable numbers of
atients who showed results discordant with the evidence; thus,
t is important to know and to gain insight into the exceptional,
ut common cases. For instance, chronic beta-blockade is an
stablished therapeutic strategy in patients with chronic heart
ailure, but does not necessarily improve ventricular function in
878-5409/$ – see front matter © 2013 Published by Elsevier Ltd on behalf of Japanese Co
ttp://dx.doi.org/10.1016/j.jccase.2013.10.012the patients. If there is a patient in whom beta-blockade did not
work with some evidence accounting for why it did not work in
this particular patient, many cardiologists would be interested in
a report of this.
Alternatively, there are many new imaging and laboratory
technologies emerging for the advancement of diagnosis and
treatment of cardiovascular diseases, and it is also intriguing to
know the value and limitations of the new technologies even on a
case-by-case basis in the initial stage. In addition, new
technologies may  provide a clue to gain insight into the improved
understanding of the pathophysiology of disease. Such a report
may  also draw the attention of many readers. Thus, case reports
are still necessary even in the era of mass data or evidence-based
medicine.
We need a great deal of help from all of you, readers and
editorial board members, and look forward to sharing the journal
with you all. We  sincerely encourage all of you to submit case
report articles excelling in originality to the JC Cases.
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